The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Open accessAbstract
Applications of adenine base editors (ABEs) have been constrained by the limited compatibility of the deoxyadenosine deaminase component with Cas homologs other than SpCas9. We evolved the deaminase component of ABE7.10 using phage-assisted non-continuous and continuous evolution (PANCE and PACE), which resulted in ABE8e. ABE8e contains eight additional mutations that increase activity (k app) 590-fold compared with that of ABE7.10. ABE8e offers substantially improved editing efficiencies when paired with a variety of Cas9 or Cas12 homologs. ABE8e is more processive than ABE7.10, which could benefit screening, disruption of regulatory regions and multiplex base editing applications. A modest increase in Cas9-dependent and -independent DNA off-target editing, and in transcriptome-wide RNA off-target editing can be ameliorated by the introduction of an additional mutation in the TadA-8e domain. Finally, we show that ABE8e can efficiently install natural mutations that upregulate fetal hemoglobin expression in the BCL11A enhancer or in the the HBG promoter in human cells, targets that were poorly edited with ABE7.10. ABE8e augments the effectiveness and applicability of adenine base editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“ABE8e has an “editing window,” the nucleotides accessible for deamination, of positions 4–9 in the protospacer (11–16 bases upstream from the PAM).16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, accumulative studies have proved that sgRNA-independent off-target effects also exist, urging unbiased experimental detection and validation (Richter et al., 2020; O'Geen et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The sgRNA-independent DNA editing is likely deposited on loci where DNA unwinds into an R-loop so single-strand genomic DNA is exposed to deaminases”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ABE8e, a variant published in 2020, exhibits a 590-fold increase in activity due to numerous mutations in the TadA deaminase domain.16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Truncated gRNA: truncated by 2-3bp at 5’ end | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Extended gRNA: GGX20 | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Self-citationClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
Liu, Z., Lu, Z., Yang, G., Huang, S., Li, G., Feng, S., Liu, Y., Li, J., Yu, W., Zhang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04768-7 · Cited by 2,103
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Self-citationCRISPResso2 provides accurate and rapid genome editing sequence analysis
Clement, K., Rees, H. A., Canver, M. C., Gehrke, J. M., Farouni, R., Hsu, J. Y., Cole, M. A., Liu, D. R., Joung, J. K., Bauer, D. E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0032-3 · Cited by 1,656
Self-citation
Cited by
Sorted by citations
Items 301–400 of 1,000
Development of multiplexed orthogonal base editor (MOBE) systems
Cowan, Q. T., Gu, S., Gu, W., Ranzau, B. L., Simonson, T. S., & Komor, A. C. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02240-0 · Cited by 26
Yu, S.-Y., Carlaw, T., Thomson, T., Birkenshaw, A., Basha, G., Kurek, D. Z., Huang, C., Kulkarni, J. A., Zhang, L., & Ross, C. J. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.009 · Cited by 27
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
Morrison, M. S., Wang, T., Raguram, A., Hemez, C. F., & Liu, D. R. (2021) · Nature Communications · doi:10.1038/s41467-021-26279-8 · Cited by 27
Self-citationAutomated high-throughput genome editing platform with an AI learning in situ prediction model
Li, S., An, J., Li, Y., Zhu, X., Zhao, D., Wang, L., Sun, Y., Yang, Y., Bi, C., Zhang, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35056-0 · Cited by 26
Schuster, S. L., Arora, S., Wladyka, C. L., Itagi, P., Corey, L., Young, D., Stackhouse, B. L., Kollath, L. A., Wu, Q. V., Corey, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112840 · Cited by 28
Kennedy, P. H., Sheikh, A. A. D., Balakar, M., Jones, A. C., Olive, M. E., Hegde, M., Matias, M. I., Pirete, N., Burt, R. A., Levy, J. M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02256-z · Cited by 30
Self-citationExploring the potential of cell-derived vesicles for transient delivery of gene editing payloads
Leandro, K., Rufino‐Ramos, D., Breyne, K., Ianni, E. D., Lopes, S., Nobre, R. J., Kleinstiver, B. P., Perdigão, P. R. L., Breakefield, X. O., & de Almeida, L. P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115346 · Cited by 27
CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders
Cabré-Romans, J.-J., & Cuella-Martin, R. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1553590 · Cited by 33
Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing
Denes, C. E., Cole, A. J., Aksoy, Y. A., Li, G., Neely, G. G., & Hesselson, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168571 · Cited by 28
Exploring C-to-G and A-to-Y Base Editing in Rice by Using New Vector Tools
Zeng, D., Zheng, Z., Liu, Y., Liu, T., Li, T., Liu, J., Luo, Q., Xue, Y., Li, S., Chai, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147990 · Cited by 25
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
Zhou, L., & Yao, S. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00115-5 · Cited by 29
Hao, W., Cui, W., Liu, Z., Suo, F., Wu, Y., Han, L., & Zhou, Z. (2024) · Advanced Science · doi:10.1002/advs.202309767 · Cited by 25
Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
Wang, P., Bailin, P. L., Zhu, M., Han, R. Y., Guo, S., & Han, R. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.11.010 · Cited by 29
Wu, L., Jiang, S., Shi, M., Yuan, T., Li, Y., Huang, P., Li, Y., Zuo, E., Zhou, C., & Sun, Y. (2024) · Genome biology · doi:10.1186/s13059-024-03434-0 · Cited by 28
Tálas, A., Simon, D. A., Kulcsár, P. I., Varga, É., Krausz, S. L., & Welker, E. (2021) · Nature Communications · doi:10.1038/s41467-021-26461-y · Cited by 25
Jayarajan, V., Kounatidou, E. E., Qasim, W., & Di, W. (2021) · Experimental Dermatology · doi:10.1111/exd.14314 · Cited by 25
Cao, X., Guo, J., Huang, S., Yu, W., Li, G., An, L., Li, X., Tao, W., Liu, Q., Huang, X., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.032 · Cited by 24
Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies
Barefield, D. Y., Álvarez-Arce, A., & Araujo, K. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01876-9 · Cited by 30
Gene editing innovations and their applications in cardiomyopathy research
Kyriakopoulou, E., Monnikhof, T., & van Rooij, E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050088 · Cited by 26
RNA molecular recording with an engineered RNA deaminase
Lin, Y., Kwok, S., Hein, A. E., Thai, B., Alabi, Y., Ostrowski, M. S., Wu, K., & Floor, S. N. (2023) · Nature Methods · doi:10.1038/s41592-023-02046-z · Cited by 25
Base editing of the mutated TERT promoter inhibits liver tumor growth
Zhao, G., Ma, Q., Huang, Y., Jiang, H., Xu, Q., Luo, S., Meng, Z., Liu, J., Zhu, L., Lin, Q., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000700 · Cited by 23
Genome-scale exon perturbation screens uncover exons critical for cell fitness
Xiao, M., Damodaran, A. P., Kumari, B., Dickson, E., Xing, K., On, T. A., Parab, N., King, H. E., Perez, A. R., Guiblet, W. M., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.05.024 · Cited by 23
Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system
Wang, L., & Han, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38588 · Cited by 26
Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1
Park, S.-J., Ju, S., Jung, W. J., Jeong, T. Y., Yoon, D. E., Lee, J., Yang, J., Lee, H., Choi, J., Kim, H. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56048-w · Cited by 25
Leveraging base excision repair for efficient adenine base editing of mitochondrial DNA
Fan, Y., Xu, W., Gao, B., Qin, H., Wu, X., Wei, J., Ni, Q., Zhou, L., Xiang, J., Wu, J., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02608-w · Cited by 28
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG
Yu, S.-Y., Birkenshaw, A., Thomson, T., Carlaw, T., Zhang, L., & Ross, C. J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0109 · Cited by 23
New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies
Pulman, J., Sahel, J., & Dalkara, D. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0141 · Cited by 25
Innate programmable DNA binding by CRISPR-Cas12m effectors enable efficient base editing
Bigelyte, G., Duchovska, B., Žedaveinytė, R., Sasnauskas, G., Šinkūnas, T., Dalgėdienė, I., Tamulaitienė, G., Šilanskas, A., Kazlauskas, D., Valančauskas, L., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae016 · Cited by 23
Improving the Precision of Base Editing by Bubble Hairpin Single Guide RNA
Hu, Z., Wang, Y., Liu, Q., Qiu, Y., Zhong, Z., Li, K., Li, W., Deng, Z., & Sun, Y. (2021) · mBio · doi:10.1128/mbio.00342-21 · Cited by 23
Šikrová, D., Cadar, V. A., Ariyürek, Y., Laros, J. F. J., Balog, J., & van der Maarel, S. M. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.05.020 · Cited by 26
CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing
Pedrazzoli, E., Demozzi, M., Visentin, E., Ciciani, M., Bonuzzi, I., Pezzè, L., Lucchetta, L., Maule, G., Amistadi, S., Esposito, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47800-9 · Cited by 26
Musolino, P. L., Rosser, S. J., Brittan, M., Newby, D. E., Berry, C., Riley, P. R., Giacca, M., Hajjar, R. J., & Baker, A. H. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf109 · Cited by 23
Villiger, L., Schmidheini, L., Mathis, N., Rothgangl, T., Marquart, K. F., & Schwank, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.025 · Cited by 21
Points of View on the Tools for Genome/Gene Editing
Chuang, C.-K., & Lin, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189872 · Cited by 26
TadA orthologs enable both cytosine and adenine editing of base editors
Zhang, S., Yuan, B., Cao, J., Song, L., Chen, J., Qiu, J., Qiu, Z., Zhao, X., Chen, J., & Cheng, T. (2023) · Nature Communications · doi:10.1038/s41467-023-36003-3 · Cited by 23
HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing
Yang, C., Ma, Z., Wang, K., Dong, X., Huang, M., Li, Y., Zhu, X., Li, J., Cheng, Z., Bi, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38193-2 · Cited by 22
Shelake, R. M., Pramanik, D., & Kim, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031145 · Cited by 21
Zhao, N., Zhou, J., Tao, T., Tang, J., Tang, J., Li, D., Gou, S., Guan, Z., Olajide, J. S., Lin, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52483-3 · Cited by 25
Wang, Z., Liu, X., Xiaodong, X., Deng, L., Zheng, H., Pan, H., Li, D., Li, L., & Zhong, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115663 · Cited by 21
A New Era in Herbicide-Tolerant Crops Development by Targeted Genome Editing
Gosavi, G., Ren, B., Li, X., Zhou, X., Spetz, C., & Zhou, H. (2022) · ACS Agricultural Science & Technology · doi:10.1021/acsagscitech.1c00254 · Cited by 21
CRISPR-Cas9 base editors and their current role in human therapeutics
Lahr, W. S., Sipe, C. J., Skeate, J. G., Webber, B. R., & Moriarity, B. S. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2022.11.013 · Cited by 21
A chemically controlled Cas9 switch enables temporal modulation of diverse effectors
Wei, C. T., Popp, N. A., Peleg, O., Powell, R. L., Borenstein, E., Maly, D. J., & Fowler, D. M. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01278-6 · Cited by 21
Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM
Qi, T., Wang, Y., Yang, Y., Gao, S., Liu, J., Huang, Q., Tian, Y., Tang, J., Zheng, W., & Wang, Y. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01481-5 · Cited by 23
Functionalized extracellular nanovesicles as advanced CRISPR delivery systems
Wang, S., Kong, H., Zhuo, C., Liu, L., Lv, S., Cheng, D., Lao, Y., Tao, Y., & Li, M. (2024) · Biomaterials Science · doi:10.1039/d4bm00054d · Cited by 22
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope
Bamidele, N., Zhang, H., Dong, X., Cheng, H., Gaston, N., Feinzig, H., Cao, H., Kelly, K. L., Watts, J. K., Xie, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45763-5 · Cited by 24
CRISPR/Cas system-mediated base editing in crops: recent developments and future prospects
Hillary, V. E., & Ceasar, S. A. (2024) · Plant Cell Reports · doi:10.1007/s00299-024-03346-0 · Cited by 24
Molecular signaling pathways in osteoarthritis and biomaterials for cartilage regeneration: a review
Hiruthyaswamy, S. P., Bose, A., Upadhyay, A., Raha, T., Bhattacharjee, S., Singha, I., Ray, S., Macarius, N. M. N., Viswanathan, P., & Deepankumar, K. (2025) · Bioengineered · doi:10.1080/21655979.2025.2501880 · Cited by 24
Shao, M., Zhang, Z., Jin, X., Ding, J., & Chen, G. (2025) · Nature Communications · doi:10.1038/s41467-025-61354-4 · Cited by 20
Research progress of base editing and prime editing tools based on the CRISPR/Cas system
Gao, H., Gao, S., Kan, G., Valentovich, L. N., & An, Y. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102771 · Cited by 26
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 21
Challenges of Gene Editing Therapies for Genodermatoses
Brooks, I. R., Sheriff, A., Moran, D., Wang, J., & Jackow, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032298 · Cited by 23
Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery
Kweon, J., Jang, A.-H., Kwon, E., Kim, U. G., Shin, H. R., See, J.-E., Jang, G., Lee, C., Koo, T., Kim, S., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00938-w · Cited by 21
Advances in CRISPR/Cas gene therapy for inborn errors of immunity
Liu, X., Li, G., Liu, Y., Zhou, F., Huang, X., & Li, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111777 · Cited by 21
Giner, G., Ikram, S., Herold, M. J., & Papenfuss, A. T. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad205 · Cited by 22
Sretenovic, S., Green, Y., Wu, Y., Cheng, Y., Zhang, T., Eck, J. M. V., & Qi, Y. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad347 · Cited by 20
Single-Base Resolution Detection of N6-Methyladenosine in RNA by Adenosine Deamination Sequencing
Shao, W.-X., Min, Y.-H., Chen, W., Xiong, J., Guo, X., Xie, N., Zhang, S., Yu, S.-Y., Xie, C., Feng, Y., et al. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00502 · Cited by 20
Chen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 23
Base editing as a genetic treatment for spinal muscular atrophyPreprint
Alves, C. R. R., Ha, L. L., Yaworski, R., Lazzarotto, C. R., Christie, K. A., Reilly, A., Beauvais, A., Doll, R. M., de la Cruz, D., Maguire, C. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.20.524978 · Cited by 20
Advancing PAM-less genome editing in soybean using CRISPR-SpRY
Chen, X., Zhong, Z., Tang, X. D., Yang, S., Zhang, Y., Wang, S., Liu, Y., Zheng, X., Feng, X., Zhang, Y., et al. (2024) · Horticulture Research · doi:10.1093/hr/uhae160 · Cited by 20
Lokya, V., Singh, S., Chaudhary, R., Jangra, A., & Tiwari, S. (2025) · Plant Molecular Biology · doi:10.1007/s11103-025-01600-x · Cited by 21
Xu, S., Liang, D., Wang, Q., Cheng, Y., Xie, D., Yang, G., Zhang, H., Feng, C., Zhao, F., Ren, W., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01480-y · Cited by 32
Lazzarotto, C. R., Katta, V., Li, Y., Manquen, G., Wood, R. K., Chyr, J., Urbina, E., Matsubara, A., Lee, G., Wu, X., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02948-7 · Cited by 23
Development of CRISPR technology for precise single-base genome editing: a brief review
Lee, H. K., Oh, Y., Hong, J., Lee, S. H., & Hur, J. K. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.2.217 · Cited by 20
Sophisticated CRISPR/Cas tools for fine-tuning plant performance
Capdeville, N., Merker, L., Schindele, P., & Puchta, H. (2020) · Journal of Plant Physiology · doi:10.1016/j.jplph.2020.153332 · Cited by 21
Dissecting Plant Gene Functions Using CRISPR Toolsets for Crop Improvement
Zhang, R., Li, B., Yang, Z.-G., Huang, J., Sun, W.-H., Bhanbhro, N., Liu, W., & Chen, K. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c01754 · Cited by 20
Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
Haideri, T., Howells, A. R., Jiang, Y., Yang, J., Bao, X., & Lian, X. L. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100290 · Cited by 18
Genome editing in cancer: Challenges and potential opportunities
Breier, D., & Peer, D. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.08.013 · Cited by 21
Clinical Approaches for Mitochondrial Diseases
Hong, S., Kim, S., Kim, K., & Lee, H. (2023) · Cells · doi:10.3390/cells12202494 · Cited by 25
Development of TALE‐adenine base editors in plants
Zhang, D., & Boch, J. (2023) · Plant Biotechnology Journal · doi:10.1111/pbi.14246 · Cited by 20
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo
Zhang, H., Kelly, K. L., Lee, J. L. C., Echeverria, D., Cooper, D., Panwala, R., Amrani, N., Chen, Z., Gaston, N., Wagh, A. A., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1125 · Cited by 19
Self-citationMengiste, A. A., McDonald, J. L., Tran, M. T. N., Plank, A. V., Wilson, R. H., Butty, V. L., & Shoulders, M. D. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00316 · Cited by 19
Catalytic and noncatalytic functions of DNA polymerase κ in translesion DNA synthesis
Sellés‐Baiget, S., Ambjørn, S. M., Carli, A., Hendriks, I. A., Gallina, I., Davey, N. E., Benedict, B., Zarantonello, A., Gadi, S. A., Meeusen, B., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01395-3 · Cited by 23
A System for the Evolution of Protein–Protein Interaction Inducers
Dewey, J. A., Azizi, S., Lu, V., & Dickinson, B. C. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00276 · Cited by 19
Wang, J., Zhang, L., Wu, G., Wu, J., Zhou, X., Chen, X., Liu, Q., Jiao, Y., Liu, Q., Liang, P., et al. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.04.013 · Cited by 20
CRISPR Technology and Its Emerging Applications
Zhang, X. E., Ma, D., & Liu, F. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf034 · Cited by 21
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
Wu, Y., Xiao, Y., & Tang, W. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02678-w · Cited by 23
Botchkarev, V. V., Harrington, S., Stoppato, M., Justen, A., Kimber, C., Kapuria, A., Gibson, K. M., Chu, C.-S., Xu, Y., Haugh, K. A., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02915-2 · Cited by 22
Engineered base editors with reduced bystander editing through directed evolution
Perrotta, R. M., Vinke, S., Ferreira, R., Moret, M., Mahas, A., Chiappino-Pepe, A., Riedmayr, L. M., Mehra, A.-T., Lehmann, L. S., & Church, G. M. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02937-w · Cited by 26
Base Editing in Human Cells to Produce Single‐Nucleotide‐Variant Clonal Cell Lines
Vásquez, C. A., Cowan, Q. T., & Komor, A. C. (2020) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.129 · Cited by 20
Reconstruction of evolving gene variants and fitness from short sequencing reads
Shen, M. W., Zhao, K. T., & Liu, D. R. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00876-6 · Cited by 18
Self-citationInhibition of base editors with anti-deaminases derived from viruses
Liu, Z., Chen, S., Lai, L., & Li, Z. (2022) · Nature Communications · doi:10.1038/s41467-022-28300-0 · Cited by 19
Kaukonen, M. K., McClements, M. E., & MacLaren, R. E. (2022) · Genes · doi:10.3390/genes13081327 · Cited by 19
Precise genome editing with base editors
Liu, H., Zhu, Y., Li, M., & Gu, Z. (2023) · Medical Review · doi:10.1515/mr-2022-0044 · Cited by 19
Characterizing off-target effects of genome editors
Rao, X., Zhao, H., Shao, C., & Yi, C. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100480 · Cited by 19
Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells
Park, J.-C., Park, M. J., Lee, S.-Y., Kim, D., Kim, K.-T., Jang, H., & Cha, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03394-5 · Cited by 17
Xia, K., Wang, F., Tan, Z., Zhang, S., Lai, X., Ou, W., Yang, C., Chen, H., Peng, H. Y., Luo, P., et al. (2023) · Advanced Science · doi:10.1002/advs.202300993 · Cited by 20
In vivo base editing rescues primary hyperoxaluria type 1 in rats
Chen, Z., Zhang, D., Zheng, R., Yang, L., Huo, Y., Zhang, D., Fang, X., Li, Y., Xu, G., Li, D., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.11.029 · Cited by 19
Base editing effectively prevents early-onset severe cardiomyopathy in Mybpc3 mutant mice
Wu, S., Yang, P., Geng, Z., Li, Y., Guo, Z., Lou, Y., Zhang, S., Xiong, J., Hu, H., Guo, X., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00930-7 · Cited by 19
Continual improvement of CRISPR ‐induced multiplex mutagenesis in Arabidopsis
Develtere, W., Decaestecker, W., Rombaut, D., Anders, C., Clicque, E., Vuylsteke, M., & Jacobs, T. B. (2024) · The Plant Journal · doi:10.1111/tpj.16785 · Cited by 18
Emerging trends in virus and virus-like particle gene therapy delivery to the brain
Mandalawatta, H. P. P., Rajendra, K. C., Fairfax, K. A., & Hewitt, A. W. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102280 · Cited by 18
AAV-mediated gene therapies by miniature gene editing tools
Kong, X., Li, T., & Yang, H. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2608-5 · Cited by 18
Celotti, M., Derks, L. L. M., van Es, J., van Boxtel, R., Clevers, H., & Geurts, M. H. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103189 · Cited by 17
Mikkelsen, N. S., Ravendran, S., Broksø, A. D., Skjelbostad, S. F., Pedersen, M. G., Fang, H., Terkelsen, T., Thomsen, M. K., & Bak, R. O. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.032 · Cited by 18
Recent Advances in Double-Strand Break-Free Kilobase-Scale Genome Editing Technologies
Tou, C. J., & Kleinstiver, B. P. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00311 · Cited by 17
Editing human hematopoietic stem cells: advances and challenges
Bhoopalan, S. V., Yen, J. S., Levine, R. M., & Sharma, A. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.08.003 · Cited by 18
Joynt, A. T., Kavanagh, E. W., Newby, G. A., Mitchell, S., Eastman, A. C., Paul, K. C., Bowling, A. D., Osorio, D. L., Merlo, C. A., Patel, S. U., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.020 · Cited by 16
Self-citationEngineered deaminases as a key component of DNA and RNA editing tools
Budzko, L., Hoffa-Sobiech, K., Jackowiak, P., & Figlerowicz, M. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102062 · Cited by 18
An ultra-compact promoter drives widespread neuronal expression in mouse and monkey brains
Wang, J., Lin, J., Chen, Y., Liu, J., Zheng, Q., Mao, D., Wang, R. L., Zhang, Y., Feng, S., Xu, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113348 · Cited by 17
CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering
Eghbalsaied, S., Lawler, C., Petersen, B., Hajiyev, R. A., Bischoff, S. R., & Frankenberg, S. (2024) · Gene Therapy · doi:10.1038/s41434-023-00434-w · Cited by 20
Metadata
- Authors
- Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., Doudna, J. A., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2020-03-16
- Volume
- 38
- Issue
- 7
- Pages
- 883-891
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7357821
- OpenAlex
- W3012327875
- Cited by
- 1,020
- References
- 60
- Citations by year
- 2026: 158 · 2025: 196 · 2024: 192 · 2023: 192 · 2022: 148 · 2021: 103 · 2020: 29
- FWCI
- 38.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-20)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL053749)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- adenine base editing, ABE8e, phage-assisted continuous evolution, Cas12, processivity, off-target editing, fetal hemoglobin, PAM site
- MeSH terms
- Gene Editing, Adenine, Adenosine Deaminase, Bacteriophages, DNA, Humans, Mutation, RNA, Mutagenesis, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
